Literature DB >> 18524993

Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks.

Annahita Sallmyr1, Alan E Tomkinson, Feyruz V Rassool.   

Abstract

Expression of oncogenic BCR-ABL in chronic myeloid leukemia (CML) results in increased reactive oxygen species (ROS) that in turn cause increased DNA damage, including DNA double-strand breaks (DSBs). We have previously shown increased error-prone repair of DSBs by nonhomologous end-joining (NHEJ) in CML cells. Recent reports have identified alternative NHEJ pathways that are highly error prone, prompting us to examine the role of the alternative NHEJ pathways in BCR-ABL-positive CML. Importantly, we show that key proteins in the major NHEJ pathway, Artemis and DNA ligase IV, are down-regulated, whereas DNA ligase IIIalpha, and the protein deleted in Werner syndrome, WRN, are up-regulated. DNA ligase IIIalpha and WRN form a complex that is recruited to DSBs in CML cells. Furthermore, "knockdown" of either DNA ligase IIIalpha or WRN leads to increased accumulation of unrepaired DSBs, demonstrating that they contribute to the repair of DSBs. These results indicate that altered DSB repair in CML cells is caused by the increased activity of an alternative NHEJ repair pathway, involving DNA ligase IIIalpha and WRN. We suggest that, although the repair of ROS-induced DSBs by this pathway contributes to the survival of CML cells, the resultant genomic instability drives disease progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18524993      PMCID: PMC2967309          DOI: 10.1182/blood-2007-07-104257

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  48 in total

1.  Coupled homologous and nonhomologous repair of a double-strand break preserves genomic integrity in mammalian cells.

Authors:  C Richardson; M Jasin
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Lack of WRN results in extensive deletion at nonhomologous joining ends.

Authors:  Junko Oshima; Shurong Huang; Chong Pae; Judith Campisi; Robert H Schiestl
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

3.  The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases.

Authors:  P Mohaghegh; J K Karow; R M Brosh; V A Bohr; I D Hickson
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

4.  Increased error-prone non homologous DNA end-joining--a proposed mechanism of chromosomal instability in Bloom's syndrome.

Authors:  Terry J Gaymes; Phillip S North; Nicola Brady; Ian D Hickson; Ghulam J Mufti; Feyruz V Rassool
Journal:  Oncogene       Date:  2002-04-11       Impact factor: 9.867

5.  Requirements for the nucleolytic processing of DNA ends by the Werner syndrome protein-Ku70/80 complex.

Authors:  B Li; L Comai
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

Review 6.  Chronic myelogenous leukemia.

Authors:  B J Druker; C L Sawyers; R Capdeville; J M Ford; M Baccarani; J M Goldman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2001

7.  Does the bcr/abl-mediated increase in the efficacy of DNA repair play a role in the drug resistance of cancer cells?

Authors:  Ireneusz Majsterek; Janusz Blasiak; Wojciech Mlynarski; Grazyna Hoser; Tomasz Skórski
Journal:  Cell Biol Int       Date:  2002       Impact factor: 3.612

8.  Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimer.

Authors:  Terry J Gaymes; Ghulam J Mufti; Feyruz V Rassool
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

9.  Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis.

Authors:  Artur Slupianek; Grazyna Hoser; Ireneusz Majsterek; Agnieszka Bronisz; Maciej Malecki; Janusz Blasiak; Richard Fishel; Tomasz Skorski
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

10.  Homologous recombination and the yKu70/80 complex exert opposite roles in resistance against the killer toxin from Pichia acaciae.

Authors:  Roland Klassen; Stefan Krampe; Friedhelm Meinhardt
Journal:  DNA Repair (Amst)       Date:  2007-08-30
View more
  78 in total

1.  Genomic instability in chronic myeloid leukemia: targets for therapy?

Authors:  N Muvarak; P Nagaria; F V Rassool
Journal:  Curr Hematol Malig Rep       Date:  2012-06       Impact factor: 3.952

2.  Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end-joining.

Authors:  Anastazja Grabarz; Aurélia Barascu; Josée Guirouilh-Barbat; Bernard S Lopez
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

3.  Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.

Authors:  L A Tobin; C Robert; A P Rapoport; I Gojo; M R Baer; A E Tomkinson; F V Rassool
Journal:  Oncogene       Date:  2012-05-28       Impact factor: 9.867

Review 4.  Structure and function of the DNA ligases encoded by the mammalian LIG3 gene.

Authors:  Alan E Tomkinson; Annahita Sallmyr
Journal:  Gene       Date:  2013-09-05       Impact factor: 3.688

5.  Human Mre11/human Rad50/Nbs1 and DNA ligase IIIalpha/XRCC1 protein complexes act together in an alternative nonhomologous end joining pathway.

Authors:  Julie Della-Maria; Yi Zhou; Miaw-Sheue Tsai; Jeff Kuhnlein; James P Carney; Tanya T Paull; Alan E Tomkinson
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

6.  Mycobacterium tuberculosis Ku can bind to nuclear DNA damage and sensitize mammalian cells to bleomycin sulfate.

Authors:  Reneau Castore; Cameron Hughes; Austin Debeaux; Jingxin Sun; Cailing Zeng; Shih-Ya Wang; Kelly Tatchell; Runhua Shi; Kyung-Jong Lee; David J Chen; Lynn Harrison
Journal:  Mutagenesis       Date:  2011-08-02       Impact factor: 3.000

7.  Progression of chromosomal damage induced by etoposide in G2 phase in a DNA-PKcs-deficient context.

Authors:  Micaela Palmitelli; Marcelo de Campos-Nebel; Marcela González-Cid
Journal:  Chromosome Res       Date:  2015-07-08       Impact factor: 5.239

8.  BCR/ABL downregulates DNA-PK(CS)-dependent and upregulates backup non-homologous end joining in leukemic cells.

Authors:  Tomasz Poplawski; Janusz Blasiak
Journal:  Mol Biol Rep       Date:  2009-08-21       Impact factor: 2.316

Review 9.  MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings.

Authors:  Mitch McVey; Sang Eun Lee
Journal:  Trends Genet       Date:  2008-09-21       Impact factor: 11.639

10.  Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining.

Authors:  Jinshui Fan; Carine Robert; Yoon-Young Jang; Hua Liu; Saul Sharkis; Stephen Bruce Baylin; Feyruz Virgilia Rassool
Journal:  Mutat Res       Date:  2011-06-28       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.